AeroLeads people directory · profile

Eric Rojas Email & Phone Number

Dynamic Senior Finance & Investor Relations Executive | Proven Leader in Strategic Financial Management, IR, and Alliance Management for Global Biopharma | Expertise in Elevating Corporate Value | Non-Profit Volunteer
Location: Lexington, Massachusetts, United States 8 work roles 1 school
LinkedIn matched
✓ Verified August 2026 3 data sources Profile completeness 71%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Dynamic Senior Finance & Investor Relations Executive | Proven Leader in Strategic Financial Management, IR, and Alliance Management for Global Biopharma | Expertise in Elevating Corporate Value | Non-Profit Volunteer
Location
Lexington, Massachusetts, United States

Who is Eric Rojas? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Eric Rojas is listed as Dynamic Senior Finance & Investor Relations Executive | Proven Leader in Strategic Financial Management, IR, and Alliance Management for Global Biopharma | Expertise in Elevating Corporate Value | Non-Profit Volunteer based in Lexington, Massachusetts, United States. AeroLeads shows a matched LinkedIn profile for Eric Rojas.

Eric Rojas previously worked as Vice President, Head of Investor Relations at Stoke Therapeutics and Senior Director, Investor Relations at Vertex Pharmaceuticals. Eric Rojas holds Bachelor Of Business Administration, Accounting from University Of Notre Dame.

Profile bio

About Eric Rojas

Eric Rojas is a seasoned finance and investor relations leader with over two decades of experience driving shareholder value and building investor confidence in the biotech and pharmaceutical sectors. In 2024, Eric executed on an upsized $125 million secondary offering that was 7x’s over-subscribed as Vice President Investor Relations for Stoke Therapeutics working closely with investors and the banking team.As Senior Director of Investor Relations at Vertex Pharmaceuticals, he played a pivotal role in securing full valuation of the company’s cystic fibrosis business by effectively educating investors and aligning market expectations with strategic execution. His deep relationships with internal and external stakeholders, including over 20 sell-side analysts, ensured that Vertex was consistently positioned for success in the eyes of the investment community.Previously, Eric led Investor Relations at Shire plc, where he enhanced the company’s image and helped articulate its growth strategy to global investors and analysts. His extensive experience spans finance operations, corporate messaging, and managing expectations for product launches, such as the US launch of VYVANSE for ADHD and the global launch of Elaprase™ for Hunter Syndrome.Eric’s career began at Arthur Andersen LLP, where he honed his expertise in financial reporting, audits, and SEC compliance, setting the foundation for his successful trajectory in corporate finance and investor relations leadership. With a proven track record of managing cross-functional teams, executing financial strategies, and implementing enterprise resource planning systems, Eric is a trusted financial strategist with a commitment to driving growth and maximizing shareholder value.

8 roles

Eric Rojas work experience

A career timeline built from the work history available for this profile.

Vice President, Head Of Investor Relations

Bedford, Massachusetts, Us

Apr 2021 - Jul 2024

Senior Director, Investor Relations

Tokyo, Jp, Jp

• Oversee Investor Relations (IR) activities in order to increase shareholder value• Articulate an in-depth understanding of Shire’s business, growth strategy, commercial plan, pipeline and financials• Work with Shire’s Executive Committee and Global Communications Strategy Team to ensure key corporate messages are communicated effectively• Build and maintain strong relationships with equity analysts covering Shire and investors globally to ensure that the Company is positioned to meet expectations

Feb 2007 - May 2014

Controller

Shire Human Genetic Therapies

• f/k/a Transkaryotic Therapies (TKT Inc)• Responsible for finance operations infrastructure• Implemented significant systems improvements and efficiency, including financial close process within 1 month of acquisition by Shire plc, Ross Enterprise Resource Planning software, Sales Order Processing system, and Concur Technologies T&E software.

Aug 2005 - Jan 2007

Senior Manager, Finance Operations

Transkaryotic Therapies Inc.

• Prepared monthly financial statements for Controller and CFO review• Responsible for developing financial policies and procedures to ensure SOX compliance• Developed monthly management report for senior management team • Supervised, developed and evaluated senior accountants and accounts payable team• Assisted Controller with SEC reporting requirements

Sep 2001 - Jul 2005

Controller

Rhodia Chirex

• Responsible for monthly financial package for Rhodia group reporting• Prepared quarterly forecasts and managed cost center reporting for Boston subsidiary• Supervised receivables, payables, purchasing, and payroll functions

Jun 1999 - Sep 2001

Project Manager, Financial Systems

Boston, Massachusetts, Us

• Managed successful Oracle implementation for North American sites• Prepared monthly financial statements • Ensured accurate and timely financial reporting package submission to corporate utilizing Hyperion• Performed financial analysis of all strategic business units within the company

Jul 1997 - Jun 1999

Audit And Business Advisory Senior

Arthur Andersen Llp

• Planned, supervised and performed all phases of audit engagements including proposal development, budgeting, and preparation of financial statements• Performed interim and year-end audits for a multi-billion dollar publicly traded high-tech manufacturer• Reported audit findings to management of client companies including written and verbal presentations• Developed, evaluated and critiqued staff performance on each audit engagement• SEC reporting experience including initial (S-1) and secondary (S-3) public offerings

Sep 1993 - Jul 1997
1 education record

Eric Rojas education

  • University Of Notre Dame
    University Of Notre Dame
    Accounting
FAQ

Frequently asked questions about Eric Rojas

Quick answers generated from the profile data available on this page.

What is Eric Rojas's role at their current company?

Eric Rojas is listed as Dynamic Senior Finance & Investor Relations Executive | Proven Leader in Strategic Financial Management, IR, and Alliance Management for Global Biopharma | Expertise in Elevating Corporate Value | Non-Profit Volunteer.

Where is Eric Rojas based?

Eric Rojas is based in Lexington, Massachusetts, United States.

What companies has Eric Rojas worked for?

Eric Rojas has worked for Stoke Therapeutics, Vertex Pharmaceuticals, Shire Pharmaceuticals, Shire Human Genetic Therapies, and Transkaryotic Therapies Inc..

How can I contact Eric Rojas?

You can use AeroLeads to view verified contact signals for Eric Rojas, including work email, phone, and LinkedIn data when available.

What schools did Eric Rojas attend?

Eric Rojas holds Bachelor Of Business Administration, Accounting from University Of Notre Dame.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.